secwatch.observer — SEC 8-K summary
======================================

Issuer:     Benitec Biopharma Inc. (BNTC)
CIK:        0001808898
Form:       8-K
Filed at:   2022-12-12T23:59:59+00:00
Accession:  0001193125-22-302288
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Benitec Biopharma increases authorized common shares from 40M to 160M
---------------------------------------------------------------------

- Stockholders approved amendment at Dec 7, 2022 annual meeting; effective Dec 9, 2022.
- Authorized common shares increased from 40,000,000 to 160,000,000.
- Certificate of Amendment filed with Delaware Secretary of State on Dec 9, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808898/000119312522302288/0001193125-22-302288-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808898/000119312522302288/d429664d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-302288

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer